LGND News
Ligand Pharmaceuticals Incorporated
$306.20
+$7.20(+2.41%)
61
Overall
55
Value
58
Tech
71
Quality
Market Cap
$6.12B
Volume
133.03K
52W Range
$175.89 - $326.63
Target Price
$349.25
LGND news: the latest Ligand Pharmaceuticals Incorporated headlines, press releases and market updates, newest first.
Latest LGND News
- Leerink Partners Reaffirms Their Buy Rating on Ligand Pharma (LGND)TipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
- Royalty Buyout Options Pose Revenue and Cash‑Flow Risks for Ligand PharmaceuticalsTipRanks Auto-Generated Newsdesk · Nov 1, 2026
- Ligand Pharma (LGND) Gets a Buy from Bank of America SecuritiesTipRanks Auto-Generated Intelligence Newsdesk · Oct 30, 2026
- Analysts’ Top Healthcare Picks: Ligand Pharma (LGND), Kymera Therapeutics (KYMR)TipRanks Newsroom · Oct 30, 2026
- Ligand Pharma (LGND) Receives a Buy from Bank of America SecuritiesTipRanks Auto-Generated Intelligence Newsdesk · Oct 19, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $306.20 | +2.4% | 133.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW